Mutational analysis of the carboxyl-terminal region of the SV40 major capsid protein VP1

J Biochem. 2007 Feb;141(2):279-86. doi: 10.1093/jb/mvm038. Epub 2007 Feb 5.

Abstract

Virus-like particles (VLPs), a promising next-generation drug delivery vehicle, can be formed in vitro using a recombinant viral capsid protein VP1 from SV40. Seventy-two VP1 pentamers interconnect to form the T = 7d lattice of SV40 capsids, through three types of C-terminal interactions, alpha-alpha'-alpha'', beta-beta' and gamma-gamma. These appear to require VP1 conformational switch, which involve in particular the region from amino acids 301-312 (herein Region I). Here we show that progressive deletions from the C-terminus of VP1, up to 34 amino acids, cause size and shape variations in the resulting VLPs, including tubular formation, whereas deletions beyond 34 amino acids simply blocked VP1 self-assembly. Mutants carrying in Region I point mutations predicted to disrupt alpha-alpha'-alpha''-type and/or beta-beta'-type interactions formed small VLPs resembling T = 1 symmetry. Chimeric VP1, in which Region I of SV40 VP1 was substituted with the homologous region from VP1 of other polyomaviruses, assembled only into small VLPs. Together, our results show the importance of the integrity of VP1 C-terminal region and the specific amino acid sequences within Region I in the assembly of normal VLPs. By understanding how to alter VLP sizes and shapes contributes to the development of drug delivery systems using VLPs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capsid / metabolism
  • Capsid Proteins / chemistry*
  • Capsid Proteins / genetics*
  • Cell Line
  • Drug Delivery Systems / methods
  • Models, Molecular
  • Mutation
  • Polyomavirus / chemistry
  • Polyomavirus / genetics
  • Simian virus 40 / chemistry*
  • Spodoptera / cytology

Substances

  • Capsid Proteins
  • VP1 protein, polyomavirus